What’s Driving Growth in the Respiratory Inhaler Devices Market? Insights into Key Trends and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the respiratory inhaler devices market grown over the years?
The respiratory inhaler devices market has witnessed strong growth in recent years and is expected to expand from $41.35 billion in 2024 to $44.33 billion in 2025 at a CAGR of 7.2%. Key growth factors include the smoking epidemic, allergic disorders, pharmaceutical advancements, and an aging population.
What Is the forecasted market size and growth rate for the respiratory inhaler devices market?
The respiratory inhaler devices market is anticipated to witness strong growth, reaching $59.55 billion by 2029, with a CAGR of 7.7%. Growth is driven by air quality concerns, digital health adoption, regulatory focus on inhaler safety, and personalized treatment solutions. Major trends include inhaler miniaturization, eco-friendly inhalers, increased home-based care, and continued technological progress.
Get your respiratory inhaler devices market report here!
https://www.thebusinessresearchcompany.com/report/respiratory-inhaler-devices-global-market-report
What are the major factors driving growth in the respiratory inhaler devices market?
The escalation in the number of respiratory ailments is set to fuel the expansion of the respiratory inhaler devices market. These diseases, which have a significant impact on the lungs and the respiratory system, trigger breathing disorders and compromise lung function. Medical devices such as respiratory inhalers are employed to deliver drugs directly to the lungs, bringing rapid and focused relief for respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), respiratory syncytial virus infection, and other related ailments. For example, data from the Centers for Disease Control and Prevention from March 2023 reveal that 8,300 cases of tuberculosis (TB) were reported in the United States in 2022, marking an increase from the 7,874 cases reported the previous year. Given these rising rates of respiratory diseases, the market for respiratory inhaler devices is expected to grow. Another factor that plays a critical role in the expansion of the respiratory inhaler devices market is the increasing rate of smoking. Engaging in the act of smoking, most commonly in the form of puffing cigarettes, cigars, or pipes, can lead to the deterioration of the airways and the tiny air sacs, also known as alveoli, in the lungs, paving the way for lung diseases like asthma, COPD, and bronchitis. These conditions necessitate the use of respiratory inhaler devices, which substantially reduce these effects and help prevent breathing issues. Significantly, in September 2024, the Centers for Disease Control and Prevention reported that tobacco use remains the leading cause of preventable diseases and death in the U.S., as approximately 49.2 million adults, or nearly one in five, reported usage of tobacco products in 2022. Hence, the surge in smoking rates is likely to propel the market for respiratory inhaler devices.
What key areas define the segmentation of the global respiratory inhaler devices Market?
The respiratory inhaler devices market covered in this report is segmented –
1) By Product: Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers
2) By Technology: Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices
3) By Disease Indication: Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension, Other Indications
4) By End User: Hospitals And Clinics, Respiratory Care Centers, Other End Users
Subsegments:
1) By Dry Powder Inhalers: Single-Dose Inhalers, Multi-Dose Inhalers
2) By Metered Dose Inhalers: CFC-Based MDIs, HFA-Based MDIs
3) By Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13014&type=smp
What are the top market players propelling the growth of the respiratory inhaler devices industry?
Major companies operating in the respiratory inhaler devices market are Merck & Co. Inc., Novartis AG, AstraZeneca PLC, Gerresheimer AG, GlaxoSmithKline PLC, 3M, Boehringer Ingelheim International GmbH, Koninklijke Philips N.V., Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., Perrigo Company PLC, AptarGroup Inc., Recipharm AB, Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Orion Corporation, Sumitomo Pharma America Inc., Beximco Pharmaceuticals Ltd., Hovione Limited, Vectura Group Limited, H&T Presspart Manufacturing Ltd., Pari Medical Holding GmbH, OMRON Healthcare Europe B.V., Medisol Lifescience Pvt. Ltd., Consort Medical plc.
What are the key trends shaping the future of the respiratory inhaler devices market?
Key enterprises in the respiratory inhaler devices market are transitioning to advanced technologies such as metered dosage inhalers in order to maintain their market dominance. A metered dosage inhaler (MDI) is a compact aerosol apparatus that provides an accurate medication dose to the lungs, usually as a mist or inhaled spray. Case in point, in February 2022, the American consumer dispense packaging and pharmaceutical delivery devices producer, AptarGroup Inc., introduced HeroTracker Sense. This technologically advanced digital respiratory health solution transforms a traditional metered dosage inhaler (pMDI) into a smart, digital medical device. The main purpose of HeroTracker Sense is to monitor patients’ usage of MDIs and ensure they adhere to their prescribed treatment. This is aimed at enhancing the quality of life for patients globally who are living with chronic respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other respiratory complications caused by COVID-19. HeroTracker Sense offers vital analytics and insights into patient training, the initiation process, and their performance to healthcare professionals through the Aptar Pharma Cohero Health BreatheSmart Connect portal.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13014
What regions are dominating the respiratory inhaler devices market growth?
North America was the largest region in the respiratory inhaler devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in respiratory inhaler devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Respiratory Disease Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/respiratory-disease-testing-global-market-report
Respiratory Monitoring Devices Global Market Report 2024
Respiratory Devices And Equipment (Diagnostic) Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
